Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681239 · ClinicalTrials.gov registry record · Phase 3
Atkins Plus KetoCal for Childhood Epilepsy
A Phase 3 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00681239: Completed Phase 3 study, sponsored by Johns Hopkins University.
NCT00681239 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681239, a Phase 3 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The modified Atkins diet (MAD) is a relatively new, alternative dietary therapy for intractable childhood and adult epilepsy. Recent evidence suggests that a strict, highly ketotic, first month may be advantageous to both immediate and long-term efficacy. KetoCal® is a pre-mixed powder that can be used to create a 4:1 ketogenic diet shake as a meal substitute. The investigators hypothesize that substituting KetoCal® for a lunch during the initial month of the MAD will lead to improved seizure reduction over the MAD alone, as well as improved tolerability and lipid values.
Interventions
- DIETARY_SUPPLEMENT Modified Atkins diet and KetoCal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681239
The ClinicalTrials.gov registry entry for NCT00681239 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modified Atkins diet and KetoCal is the first listed.
NCT00681239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00681239 about?
NCT00681239 is a clinical study titled "Atkins Plus KetoCal for Childhood Epilepsy". The modified Atkins diet (MAD) is a relatively new, alternative dietary therapy for intractable childhood and adult epilepsy. Recent evidence suggests that a strict, highly ketotic, first month may be advantageous to both immediate and long-term efficacy. KetoCal® is a pre-mixed powder that can be u...
What is the current status of trial NCT00681239?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2008-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00681239?
The interventions under investigation include: Modified Atkins diet and KetoCal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00681239?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.